Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579
Here are highlights from Wednesday's Analyst Blog:
CF Industries Keeps It Growing
CF Industries Holdings, Inc. (NYSE: CF | Quote | Chart | News | PowerRating) has leading market shares in many key fertilizers. Strong domestic and international grain markets have produced an exceptionally high global demand for fertilizer, translating into substantially higher selling prices for all the products.
The company is likely to benefit from the proposed nitrogen facility in Peru, which will address the nitrogen demand on the west coast of Central and South America as well as Mexico, which does not have a nitrogen facility. As a result, we rate the shares a Buy with a target of $130.
Amgen Stays a Long-Term Hold
Amgen, Inc.'s (Nasdaq: AMGN | Quote | Chart | News | PowerRating) results over the past few quarters demonstrate the challenging, but stabilizing ESA market. Nevertheless, we still feel as though the pipeline is significantly undervalued, and we continue to recommend the name as a long-term Hold within the biotechnology sector.
Recent positive news on phase III denosumab is a big reason we continue to be positive on Amgen. The ESA trends are stabilizing, but it will still take a few more quarters to see exactly how the ODAC meeting and finalized label will affect sales. In the meantime, investors should focus their time on just how big denosumab and motesanib can be, because they are the next wave of potential growth.
VimpelCom Maintaining Strength
Vimpel-Communications (NYSE: VIP | Quote | Chart | News | PowerRating) delivered better-than-expected operating results in the most recent quarter, beating our estimates with strong revenue and customer growth across all its markets.
We reiterate our Buy rating based on financial metric estimates which we believe are attainable. VimpelCom is trading at 10.2x our 2008 EPADS estimates which is significantly below historical levels in previous quarters, although this metric remains at a premium to its major competitor, Mobile TeleSystems (NYSE: MBT | Quote | Chart | News | PowerRating) (its closest Russian peer). VimpelCom's shares have lost approximately 50% of its value since a 52-week high reached in December 2007.
Procter & Gamble Won't Outperform
Procter & Gamble's (NYSE: PG | Quote | Chart | News | PowerRating) management is committed to a growth strategy based on driving volume through product innovation and increasing penetration into developing markets and expanding profitability by focusing on higher margin categories. The plan is meeting with success in terms of top-line expansion, volume growth, and higher earnings.
Though the Gillette acquisition was accretive to earnings in fiscal 2008, the gross margin was negatively impacted by increased commodity and energy costs. The Hold recommendation is maintained.
Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=2649.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=2677
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4580.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
SOURCE: Zacks.com
Zacks.com Mark Vickery Web Content Editor 312-265-9380 Visit: www.zacks.com

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index